Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant

Figure 1

Change in visual acuity (ETDRS chart) over 6 months of follow-up after switch to aflibercept. Box plots representing at each time point the distribution of data from bottom to top: minimum, first quartile, median, third quartile, and maximum. p values were obtained after a paired parametric t-test after verification of the normal distribution. <0.05; <0.01; <0.001; and <0.0001.